Pharmacodynamics and safety of single-dose taspoglutide, Diabetes, Obesity and Metabolism
This multifunctional treatment platform is anticipated to accommodate the complex and dynamic biological processes involved in diabetic wound healing, thereby significantly improving the overall efficacy of wound healing treatments
Optimal dosing protocol: administer the blend 3045 minutes before sleep in a fasted state (minimum 3 hours post-meal) to align with circadian growth hormone rhythm, minimize somatostatin interference, and synchronize peptide Cmax with slow-wave sleep onset
CJC-1295, a growth hormone-releasing hormone analog, extends GH release duration, maximizing its benefits
doi: 10.1016/j.arr.2020.101123 37 LiJYanYFuYChenZYangYLiYet al
Only the iron(III) species without one ligand and the GSSG molecule remained unchanged